Hirose K, Omori Y, Higuchi R, Yamamoto M, et al. Clinicopathological Relevance of SMAD4 and RUNX3 in Patients With Resected Pancreatic Cancer. Pancreas 2025;54:e287-e294.
PMID: 40262100